Can Altimmune make your rich? Pemvidutide seems to appear superior to Semaglutide.

Greetings, fellow investors! Welcome back to ShareTreck. I'm Raj, today I am going to talk about why I think Altimmune may be ticket to riches. There was a recent study that showed that Semaglutide has some side effects potentially leading to blindness in one eye in some cases. Though the possibilities are low, this could become a warning in a label.
Meanwhile earlier Pemvidutide was superior only because it did not show muscle loss. Now with additional side effects for Semaglutide, if the FDA approves Pemvidutide, that can catapult Altimmune overnight to top spot in the obesity therapy market.
Well this is my personal opinion, not financial advice.
JOIN THE CHANNEL AS A MEMBER:
Please check out the membership offering and join me in the exciting new chapter for ShareTreck, Thanks for your support so far and looking forward to much more. Use the link below to join or click on the Join button on the bottom left of your screen or copy the link below to your browser address bar and press enter.
/ @sharetreck
Please subscribe: / @sharetreck
The videos in this channel should not be construed as financial advice. Always make sure to do your own due diligence and research.
Please do not trade or invest based on this video. Information provided in this video is not investment advice and is for entertainment purposes only.
In case of coverage of pharma companies, disease and therapy details are derived from news articles and publications by companies or research organizations. I am not a doctor but am only facilitating dissemination of published information.

[@JJthename55]

Excellent video.
Thank you.

[@ShareTreck]

Thanks 😊